Furthermore, the TLR4/MyD88 pathway plays a vital role in the trilogy of hepatitis–cirrhosis–HCC (Zare-Bidaki et al., 2014; Kang et al., 2018; Song et al., 2018). Here, TLR4 is linked to hepatocellular carcinoma.